-
Mashup Score: 1JNCCN 360 - Breast - Imlunestrant Alone and Combined With Abemaciclib in Advanced Breast Cancer - 5 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1
By continuing to browse this site you permit us and our partner s to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet-
Primary Prevention of #BreastCancer Based on #AI Risk Model: https://t.co/evGJcTZQCH #JNCCN360 #BCSM https://t.co/xuIOe0GbSp
-
-
Mashup Score: 0JNCCN 360 - Ovarian - Lainie P. Martin, MD, Antibody-Drug Conjugates and Ovarian Cancer - 14 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet-
Lainie P. Martin, MD, Antibody-Drug Conjugates and #OvarianCancer: https://t.co/fIr1FhRADa #JNCCN360 #gyncsm https://t.co/W1usWg2HcH
-
-
Mashup Score: 0JNCCN 360 - Advanced Skin Cancers - Subcutaneous Injection of Nivolumab and Hyaluronidase-nvhy Approved by the FDA - 14 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet-
Subcutaneous Injection of Nivolumab and Hyaluronidase-nvhy Approved by the FDA: https://t.co/aLbdBLiSVN #JNCCN360 #SKCSM https://t.co/2HXKQUNQxC
-
-
Mashup Score: 0JNCCN 360 - Advanced Skin Cancers - Carlo M. Contreras, MD, FACS, on Novel Therapies for Skin Cancers: A Surgical Perspective - 27 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet-
Carlo M. Contreras, MD, FACS, on Novel Therapies for #SkinCancers: A Surgical Perspective: https://t.co/3fU1rrHytz #JNCCN360 #SKCSM #surgonc https://t.co/ctC27Gbf9f
-
-
Mashup Score: 0JNCCN 360 - Breast - Does Adding Palbociclib to Combination Therapy Improve Outcomes in Metastatic Breast Cancer? - 28 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet-
Does Adding Palbociclib to Combination Therapy Improve Outcomes in Metastatic #BreastCancer? https://t.co/nKdGA0kjp3 #JNCCN360 #BCSM https://t.co/IvRO1idBZp
-
-
Mashup Score: 1JNCCN 360 - Non–Small Cell Lung Cancer - Marisa Bittoni, PhD, on Vaping, Smoking, and Lung Cancer - 28 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet-
Marisa Bittoni, PhD, on Vaping, Smoking, and #LungCancer: https://t.co/MzYTmNmop8 #JNCCN360 #LCSM https://t.co/UKtCX7CT4o
-
-
Mashup Score: 1JNCCN 360 - CLL/MCL - BRUIN CLL-321 Trial: Update on Pirtobrutinib for BTK Inhibitor–Pretreated CLL or SLL - 29 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet-
BRUIN CLL-321 Trial: Update on Pirtobrutinib for BTK Inhibitor–Pretreated #CLL or #SLL: https://t.co/g29RP3HA0E #JNCCN360 #Leusm #Lymsm https://t.co/JAxyKQYZ6T
-
-
Mashup Score: 0JNCCN 360 - Ovarian - Research Focuses on How to Boost Immunotherapy Response in Recurrent Ovarian Cancer - 29 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet-
Research Focuses on How to Boost #Immunotherapy Response in Recurrent #OvarianCancer: https://t.co/D9zpEbitaL #JNCCN360 #GynCSM #immunoonc https://t.co/L58wG1LlDR
-
-
Mashup Score: 0JNCCN 360 - Breast - Does Adding Palbociclib to Combination Therapy Improve Outcomes in Metastatic Breast Cancer? - 1 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Oncologists1Tweet-
Does Adding Palbociclib to Combination Therapy Improve Outcomes in Metastatic #BreastCancer? https://t.co/nKdGA0kjp3 #JNCCN360 #BCSM https://t.co/IvRO1idBZp
-
Imlunestrant Alone and Combined With Abemaciclib in Advanced #BreastCancer: https://t.co/tsZ7qfXE95 #JNCCN360 #BCSM https://t.co/pLNaFpmhtD